首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 赵云
2023
CA
Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis
CMLS, 10.1007/s00018-023-04971-w
CA
Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease
INT J BIOL SCI, 10.7150/ijbs.86869
CA
RIPK3-MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis
CLIN TRANSL MED, 10.1002/ctm2.1334
CA
Subphenotyping heterogeneous patients with chronic critical illness to guide individualised fluid balance treatment using machine learning: a retrospective cohort study
EClinicalMedicine, 10.1016/j.eclinm.2023.101970
CA
4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING
Cell Rep, 10.1016/j.celrep.2023.112145
2022
CA
The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages
CELL DEATH DIS, 10.1038/s41419-022-05115-x
CA
Post-Translational Modifications of STING: A Potential Therapeutic Target
Front Immunol, 10.3389/fimmu.2022.888147
CA
The IRG1-Itaconate axis: A regulatory hub for immunity and metabolism in macrophages
INT REV IMMUNOL, 10.1080/08830185.2022.2067153
CA
GSDMB N-terminal assembles in plasma membrane to execute pyroptotic cell death
GENES DIS, 10.1016/j.gendis.2021.12.022
2021
CA
Extracellular vesicles package dsDNA to aggravate Crohn's disease by activating the STING pathway
CELL DEATH DIS, 10.1038/s41419-021-04101-z
点击查看热心肠日报解读
CA
The ubiquitous role of spleen tyrosine kinase (Syk) in gut diseases: From mucosal immunity to targeted therapy
INT REV IMMUNOL, 10.1080/08830185.2021.1962860